Revision history of "Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer" (Q38445646)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

3 September 2023

28 October 2022

7 October 2021

22 May 2021

17 August 2019

23 January 2019

23 December 2018

8 November 2017

5 September 2017

3 September 2017